Listed

Prelude Therapeutics Inc

PRLDNasdaqCIK 1678660HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$5.7m, Q2 FY2026
Operating income−$15.5m, Q2 FY2026
Net income−$13.9m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reported3.0Revenue, Q3 FY2024, three months to 2024-09-30$3.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure4.0Revenue, Q4 FY2024, three months to 2024-12-31$4.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001193125-26-099428. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure6.5Revenue, Q3 FY2025, three months to 2025-09-30$6.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure5.6Revenue, Q4 FY2025, three months to 2025-12-31$5.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-10, accession 0001193125-26-099428. Derived: 12-month figure less the 9-month figure.Report this figure4.6Revenue, Q1 FY2026, three months to 2026-03-31$4.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure5.7Revenue, Q2 FY2026, three months to 2026-06-30$5.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure
Research and development$m26.3Research and development, Q3 FY2023, three months to 2023-09-30$26.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0000950170-24-122377.Report this figure30.3Research and development, Q4 FY2023, three months to 2023-12-31$30.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-10, accession 0000950170-25-035921. Derived: 12-month figure less the 9-month figure.Report this figure27.4Research and development, Q1 FY2024, three months to 2024-03-31$27.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0000950170-25-064566.Report this figure29.5Research and development, Q2 FY2024, three months to 2024-06-30$29.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0000950170-25-108417.Report this figure29.5Research and development, Q3 FY2024, three months to 2024-09-30$29.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure31.6Research and development, Q4 FY2024, three months to 2024-12-31$31.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001193125-26-099428. Derived: 12-month figure less the 9-month figure.Report this figure28.8Research and development, Q1 FY2025, three months to 2025-03-31$28.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure25.8Research and development, Q2 FY2025, three months to 2025-06-30$25.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure21.7Research and development, Q3 FY2025, three months to 2025-09-30$21.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure18.0Research and development, Q4 FY2025, three months to 2025-12-31$18.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001193125-26-099428. Derived: 12-month figure less the 9-month figure.Report this figure13.6Research and development, Q1 FY2026, three months to 2026-03-31$13.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure16.1Research and development, Q2 FY2026, three months to 2026-06-30$16.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure
Operating income$m(33.4)Operating income, Q3 FY2023, three months to 2023-09-30−$33.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122377.Report this figure(37.4)Operating income, Q4 FY2023, three months to 2023-12-31−$37.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-10, accession 0000950170-25-035921. Derived: 12-month figure less the 9-month figure.Report this figure(34.3)Operating income, Q1 FY2024, three months to 2024-03-31−$34.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0000950170-25-064566.Report this figure(37.2)Operating income, Q2 FY2024, three months to 2024-06-30−$37.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-108417.Report this figure(34.4)Operating income, Q3 FY2024, three months to 2024-09-30−$34.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure(33.8)Operating income, Q4 FY2024, three months to 2024-12-31−$33.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099428. Derived: 12-month figure less the 9-month figure.Report this figure(34.6)Operating income, Q1 FY2025, three months to 2025-03-31−$34.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure(32.2)Operating income, Q2 FY2025, three months to 2025-06-30−$32.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure(20.4)Operating income, Q3 FY2025, three months to 2025-09-30−$20.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure(17.3)Operating income, Q4 FY2025, three months to 2025-12-31−$17.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099428. Derived: 12-month figure less the 9-month figure.Report this figure(14.2)Operating income, Q1 FY2026, three months to 2026-03-31−$14.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure(15.5)Operating income, Q2 FY2026, three months to 2026-06-30−$15.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure
Net income$m(30.6)Net income, Q3 FY2023, three months to 2023-09-30−$30.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122377.Report this figure(33.1)Net income, Q4 FY2023, three months to 2023-12-31−$33.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-10, accession 0000950170-25-035921. Derived: 12-month figure less the 9-month figure.Report this figure(31.4)Net income, Q1 FY2024, three months to 2024-03-31−$31.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure(34.7)Net income, Q2 FY2024, three months to 2024-06-30−$34.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure(32.3)Net income, Q3 FY2024, three months to 2024-09-30−$32.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure(28.7)Net income, Q4 FY2024, three months to 2024-12-31−$28.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099428. Derived: 12-month figure less the 9-month figure.Report this figure(32.1)Net income, Q1 FY2025, three months to 2025-03-31−$32.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure(31.2)Net income, Q2 FY2025, three months to 2025-06-30−$31.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure(19.7)Net income, Q3 FY2025, three months to 2025-09-30−$19.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure(16.5)Net income, Q4 FY2025, three months to 2025-12-31−$16.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099428. Derived: 12-month figure less the 9-month figure.Report this figure(10.4)Net income, Q1 FY2026, three months to 2026-03-31−$10.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure(13.9)Net income, Q2 FY2026, three months to 2026-06-30−$13.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure
Diluted EPS$ per share(0.45)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0000950170-24-122377.Report this figurenot reported(0.42)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0000950170-25-064566.Report this figure(0.46)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0000950170-25-108417.Report this figure(0.43)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figurenot reported(0.42)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure(0.41)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure(0.26)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figurenot reported(0.13)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure(0.14)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure
Basic EPS$ per share(0.45)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0000950170-24-122377.Report this figurenot reported(0.42)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0000950170-25-064566.Report this figure(0.46)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0000950170-25-108417.Report this figure(0.43)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figurenot reported(0.42)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure(0.41)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure(0.26)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figurenot reported(0.13)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure(0.14)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure

Balance sheet

Cash and equivalents$26.3m, Q2 FY2026
Shareholders' equity$133.7m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m15.9Cash and equivalents, Q3 FY2023, at 2023-09-30$15.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-01, accession 0000950170-23-057523.Report this figure25.3Cash and equivalents, FY2023, at 2023-12-31$25.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-10, accession 0000950170-25-035921.Report this figure24.7Cash and equivalents, Q1 FY2024, at 2024-03-31$24.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-07, accession 0000950170-24-053940.Report this figure27.8Cash and equivalents, Q2 FY2024, at 2024-06-30$27.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-12, accession 0000950170-24-095065.Report this figure11.1Cash and equivalents, Q3 FY2024, at 2024-09-30$11.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0000950170-24-122377.Report this figure12.5Cash and equivalents, FY2024, at 2024-12-31$12.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-10, accession 0001193125-26-099428.Report this figure40.3Cash and equivalents, Q1 FY2025, at 2025-03-31$40.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0000950170-25-064566.Report this figure25.8Cash and equivalents, Q2 FY2025, at 2025-06-30$25.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0000950170-25-108417.Report this figure47.5Cash and equivalents, Q3 FY2025, at 2025-09-30$47.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure35.3Cash and equivalents, FY2025, at 2025-12-31$35.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure21.8Cash and equivalents, Q1 FY2026, at 2026-03-31$21.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure26.3Cash and equivalents, Q2 FY2026, at 2026-06-30$26.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure
Current assets$m235Current assets, Q3 FY2023, at 2023-09-30$234.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-01, accession 0000950170-23-057523.Report this figure236Current assets, FY2023, at 2023-12-31$235.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-10, accession 0000950170-25-035921.Report this figure205Current assets, Q1 FY2024, at 2024-03-31$205.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-053940.Report this figure183Current assets, Q2 FY2024, at 2024-06-30$182.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095065.Report this figure156Current assets, Q3 FY2024, at 2024-09-30$156.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122377.Report this figure136Current assets, FY2024, at 2024-12-31$135.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099428.Report this figure102Current assets, Q1 FY2025, at 2025-03-31$102.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064566.Report this figure76.9Current assets, Q2 FY2025, at 2025-06-30$76.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108417.Report this figure58.3Current assets, Q3 FY2025, at 2025-09-30$58.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure106Current assets, FY2025, at 2025-12-31$105.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure84.6Current assets, Q1 FY2026, at 2026-03-31$84.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure155Current assets, Q2 FY2026, at 2026-06-30$154.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure
Total assets$m259Total assets, Q3 FY2023, at 2023-09-30$258.5m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-01, accession 0000950170-23-057523.Report this figure278Total assets, FY2023, at 2023-12-31$277.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-10, accession 0000950170-25-035921.Report this figure247Total assets, Q1 FY2024, at 2024-03-31$247.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0000950170-24-053940.Report this figure224Total assets, Q2 FY2024, at 2024-06-30$224.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0000950170-24-095065.Report this figure197Total assets, Q3 FY2024, at 2024-09-30$197.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0000950170-24-122377.Report this figure176Total assets, FY2024, at 2024-12-31$175.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-10, accession 0001193125-26-099428.Report this figure141Total assets, Q1 FY2025, at 2025-03-31$141.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0000950170-25-064566.Report this figure115Total assets, Q2 FY2025, at 2025-06-30$114.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0000950170-25-108417.Report this figure94.8Total assets, Q3 FY2025, at 2025-09-30$94.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure141Total assets, FY2025, at 2025-12-31$141.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure120Total assets, Q1 FY2026, at 2026-03-31$119.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure189Total assets, Q2 FY2026, at 2026-06-30$189.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure
Current liabilities$m16.9Current liabilities, Q3 FY2023, at 2023-09-30$16.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-01, accession 0000950170-23-057523.Report this figure21.8Current liabilities, FY2023, at 2023-12-31$21.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-10, accession 0000950170-25-035921.Report this figure17.6Current liabilities, Q1 FY2024, at 2024-03-31$17.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-053940.Report this figure23.3Current liabilities, Q2 FY2024, at 2024-06-30$23.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095065.Report this figure22.2Current liabilities, Q3 FY2024, at 2024-09-30$22.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122377.Report this figure25.6Current liabilities, FY2024, at 2024-12-31$25.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099428.Report this figure19.8Current liabilities, Q1 FY2025, at 2025-03-31$19.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064566.Report this figure20.9Current liabilities, Q2 FY2025, at 2025-06-30$20.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108417.Report this figure18.2Current liabilities, Q3 FY2025, at 2025-09-30$18.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure53.0Current liabilities, FY2025, at 2025-12-31$53.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure41.7Current liabilities, Q1 FY2026, at 2026-03-31$41.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure38.0Current liabilities, Q2 FY2026, at 2026-06-30$38.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure
Total liabilities$m20.3Total liabilities, Q3 FY2023, at 2023-09-30$20.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-01, accession 0000950170-23-057523.Report this figure40.6Total liabilities, FY2023, at 2023-12-31$40.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-10, accession 0000950170-25-035921.Report this figure36.4Total liabilities, Q1 FY2024, at 2024-03-31$36.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0000950170-24-053940.Report this figure42.0Total liabilities, Q2 FY2024, at 2024-06-30$42.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0000950170-24-095065.Report this figure40.8Total liabilities, Q3 FY2024, at 2024-09-30$40.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0000950170-24-122377.Report this figure44.1Total liabilities, FY2024, at 2024-12-31$44.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-10, accession 0001193125-26-099428.Report this figure38.1Total liabilities, Q1 FY2025, at 2025-03-31$38.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0000950170-25-064566.Report this figure39.1Total liabilities, Q2 FY2025, at 2025-06-30$39.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0000950170-25-108417.Report this figure36.2Total liabilities, Q3 FY2025, at 2025-09-30$36.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure72.7Total liabilities, FY2025, at 2025-12-31$72.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure59.5Total liabilities, Q1 FY2026, at 2026-03-31$59.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure55.6Total liabilities, Q2 FY2026, at 2026-06-30$55.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure
Shareholders' equity$m238Shareholders' equity, Q3 FY2023, at 2023-09-30$238.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0000950170-24-122377.Report this figure237Shareholders' equity, FY2023, at 2023-12-31$237.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-10, accession 0001193125-26-099428.Report this figure211Shareholders' equity, Q1 FY2024, at 2024-03-31$210.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure182Shareholders' equity, Q2 FY2024, at 2024-06-30$182.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure156Shareholders' equity, Q3 FY2024, at 2024-09-30$156.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure131Shareholders' equity, FY2024, at 2024-12-31$131.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure103Shareholders' equity, Q1 FY2025, at 2025-03-31$103.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure75.8Shareholders' equity, Q2 FY2025, at 2025-06-30$75.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure58.5Shareholders' equity, Q3 FY2025, at 2025-09-30$58.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure68.6Shareholders' equity, FY2025, at 2025-12-31$68.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure60.2Shareholders' equity, Q1 FY2026, at 2026-03-31$60.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure134Shareholders' equity, Q2 FY2026, at 2026-06-30$133.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure

Cash flow

Operating cash flow−$15.6m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(25.7)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$25.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0000950170-24-122377. Derived: 9-month figure less the 6-month figure.Report this figure(23.6)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$23.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-10, accession 0000950170-25-035921. Derived: 12-month figure less the 9-month figure.Report this figure(31.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$31.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0000950170-25-064566.Report this figure(23.1)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$23.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0000950170-25-108417. Derived: 6-month figure less the 3-month figure.Report this figure(27.3)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$27.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-275887. Derived: 9-month figure less the 6-month figure.Report this figure(20.7)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$20.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001193125-26-099428. Derived: 12-month figure less the 9-month figure.Report this figure(34.2)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$34.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure(26.1)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$26.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-343475. Derived: 6-month figure less the 3-month figure.Report this figure(19.1)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$19.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-275887. Derived: 9-month figure less the 6-month figure.Report this figure23.1Operating cash flow, Q4 FY2025, three months to 2025-12-31$23.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001193125-26-099428. Derived: 12-month figure less the 9-month figure.Report this figure(21.7)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$21.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure(15.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$15.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-343475. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.6Capital expenditure, Q3 FY2023, three months to 2023-09-30$591.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0000950170-24-122377. Derived: 9-month figure less the 6-month figure.Report this figure1.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-10, accession 0000950170-25-035921. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2024, three months to 2024-03-31$289.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0000950170-25-064566.Report this figure0.4Capital expenditure, Q2 FY2024, three months to 2024-06-30$359.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0000950170-25-108417. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$63.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-275887. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$53.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-10, accession 0001193125-26-099428. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$47.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$20.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-343475. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-275887. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-10, accession 0001193125-26-099428. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-343475. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)98.39m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q1 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares47.4Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3047,449,811 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-01, accession 0000950170-23-057523.Report this figure47.7Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3147,737,190 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0000950170-24-053940.Report this figure56.2Diluted shares (weighted), Q1 FY2023, three months to 2023-06-3056,240,491 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-12, accession 0000950170-24-095065.Report this figure67.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3067,639,993 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0000950170-24-122377.Report this figure75.7Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3175,735,954 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0000950170-25-064566.Report this figure75.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3075,762,152 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0000950170-25-108417.Report this figure75.9Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3075,855,949 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure76.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3175,986,281 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure76.0Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3075,993,941 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure76.1Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3076,132,337 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-275887.Report this figure82.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3182,519,981 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-218173.Report this figure98.4Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3098,388,593 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure

Shares outstanding: 79.80mShares outstanding, period not labelled, at 2026-08-0679,803,485 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-343475.Report this figure at Aug 6, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.